Accelerated hematopoietic stem cell aging in a mouse model of dyskeratosis congenita responds to antioxidant treatment
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Summary: Mutations in DKC1, encoding telomerase associated protein dyskerin, cause X‐linked dyskeratosis congenita (DC), a bone marrow (BM) failure, and cancer susceptibility syndrome. Decreased accumulation of telomerase RNA resulting in excessive telomere shortening and premature cellular senescence is thought to be the primary cause of disease in X‐linked DC. Affected tissues are those that require constant renewal by stem cell activity. We previously showed that in Dkc1Δ15 mice, which contain a mutation that is a copy of a human mutation causing DC, mutant cells have a telomerase‐dependent proliferative defect and increased accumulation of DNA damage in the first generation before the telomeres are short. We now demonstrate the presence of the growth defect in Dkc1Δ15 mouse embryonic fibroblasts in vitro and show that accumulation of DNA damage and levels of reactive oxygen species increase with increasing population doublings. Treatment with the antioxidant, N‐acetyl cysteine (NAC), partially rescued the growth disadvantage of mutant cells in vitro and in vivo. Competitive BM repopulation experiments showed that the Dkc1Δ15 mutation is associated with a functional stem cell defect that becomes more severe with increasing age, consistent with accelerated senescence, a hallmark of DC hematopoiesis. This stem cell phenotype was partially corrected by NAC treatment. These results suggest that a pathogenic Dkc1 mutation accelerates stem cell aging, that increased oxidative stress might play a role in the pathogenesis of X‐linked DC, and that some manifestations of DC may be prevented or delayed by antioxidant treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Shelterin: the protein complex that shapes and safeguards human telomeres
de Lange, T. (2005) · Genes & Development · doi:10.1101/gad.1346005 · Cited by 3,056 · cited 1×
“The disease is heterogeneous in presentation, and mutations in six different genes, all encoding components of telomerase (Vulliamy & Dokal, 2008) or shelterin, (de Lange, 2005; Savage et al., 2008) the protein complex that caps and protects telomeres, have been implicated.”
Association of reactive oxygen species levels and radioresistance in cancer stem cells
Diehn, M., Cho, R. W., Lobo, N. A., Kalisky, T., Dorie, M. J., Kulp, A. N., Qian, D., Lam, J. S., Ailles, L. E., Wong, M., et al. (2009) · Nature · doi:10.1038/nature07733 · Cited by 2,555
Telomere Shortening and Tumor Formation by Mouse Cells Lacking Telomerase RNA
Blasco, M. A., Lee, H.-W., Hande, M. P., Samper, E., Lansdorp, P. M., DePinho, R. A., & Greider, C. W. (1997) · Cell · doi:10.1016/s0092-8674(01)80006-4 · Cited by 2,108
FoxOs Are Critical Mediators of Hematopoietic Stem Cell Resistance to Physiologic Oxidative Stress
Tothova, Z., Kollipara, R., Huntly, B. J., Lee, B. H., Castrillon, D. H., Cullen, D. E., McDowell, E. P., Lazo-Kallanian, S., Williams, I. R., Sears, C., et al. (2007) · Cell · doi:10.1016/j.cell.2007.01.003 · Cited by 1,562 · cited 4×
“Stem cell defects in ATM-deficient mice or in mice lacking transcription factors FoxOs 1, 3, and 5 are partially corrected by antioxidant NAC treatment (Ito et al., 2004; Tothova et al., 2007).”
BackgroundInfluentialReactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells
Ito, K., Hirao, A., Arai, F., Takubo, K., Matsuoka, S., Miyamoto, K., Ohmura, M., Naka, K., Hosokawa, K., Ikeda, Y., et al. (2006) · Nature Medicine · doi:10.1038/nm1388 · Cited by 1,362 · cited 2×
“In addition regulation of oxidative stress has been shown to be an important factor in HSC aging (Ito et al. 2004; Ito et al. 2006; Diehn et al. 2009; Abbas et al. 2010; Li and Marban, 2010).”
BackgroundRegulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells
Ito, K., Hirao, A., Arai, F., Matsuoka, S., Takubo, K., Hamaguchi, I., Nomiyama, K., Hosokawa, K., Sakurada, K., Nakagata, N., et al. (2004) · Nature · doi:10.1038/nature02989 · Cited by 1,175 · cited 8×
“Whether the increase in ROS that we observe accumulating in mutant cells is a consequence of the DNA damage Stem cell aging in Dkc1 mutant mice, B.-W. Gu et al. ª 2011 The Authors Aging Cell ª 2011 Blackwell Publishing Ltd/Anatomical Society of Great Britain and Ireland 344 response mediated by ATM ⁄ p53 ⁄ p21 (Macip…”
BackgroundInfluentialCell intrinsic alterations underlie hematopoietic stem cell aging
Rossi, D. J., Bryder, D., Zahn, J. M., Ahlenius, H., Sonu, R., Wagers, A. J., & Weissman, I. L. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503280102 · Cited by 1,152 · cited 1×
“The number of BM cells, erythroid-committed progenitor cells, and c-Kit+, Sca-1+ and Lineage) (KLS) cells (Rossi et al., 2005), a BM cell fraction enriched in functional stem cells, was Stem cell aging in Dkc1 mutant mice, B.-W. Gu et al. ª 2011 The Authors Aging Cell ª 2011 Blackwell Publishing…”
BackgroundDeficiencies in DNA damage repair limit the function of haematopoietic stem cells with age
Rossi, D. J., Bryder, D., Seita, J., Nussenzweig, A., Hoeijmakers, J., & Weissman, I. L. (2007) · Nature · doi:10.1038/nature05862 · Cited by 1,115 · cited 6×
“(Rossi et al. 2007) DNA damage triggered by the excessively short telomeres was thought to be the factor that caused loss of Gu et al.”
BackgroundResultInfluentialShort telomeres are a risk factor for idiopathic pulmonary fibrosis
Alder, J. K., Chen, J. J.-L., Lancaster, L., Danoff, S., Su, S.-C., Cogan, J. D., Vulto, I., Xie, M., Qi, X., Tuder, R. M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804280105 · Cited by 805 · cited 2×
“Telomere shortening has been thought to be the major contributor to pulmonary fibrosis in these patients (Alder et al., 2008) but perhaps increased sensitivity to oxidative stress plays an additional role in pathogenesis.”
BackgroundN-Acetylcysteine—a safe antidote for cysteine/glutathione deficiency
Atkuri, K. R., Mantovani, J. J., Herzenberg, L. A., & Herzenberg, L. A. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2007.04.005 · Cited by 721 · cited 2×
“First, we tested primary MEF cells from Dkc1Δ15/+ female mice, in the presence or absence of 100μM N-acetyl cysteine (NAC), a clinically approved antioxidant (Figure 6A) (Atkuri et al. 2007).”
Method
Cited by
How “reversible” is telomeric aging?
Epel, E. (2012) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-12-0370 · Cited by 103
Cho, J. S., Kook, S. H., Robinson, A. R., Niedernhofer, L. J., & Lee, B.-C. (2013) · Stem Cells · doi:10.1002/stem.1261 · Cited by 27
CD137 ligand reverse signaling skews hematopoiesis towards myelopoiesis during aging
Tang, Q., Koh, L. K., Jiang, D., & Schwarz, H. (2013) · Aging · doi:10.18632/aging.100588 · Cited by 14
Metadata
- Authors
- Gu, B., Fan, J., Bessler, M., & Mason, P. J.
- Venue
- Aging Cell
- Publisher
- Wiley
- Published
- 2011-02-21
- Volume
- 10
- Issue
- 2
- Pages
- 338-348
- ISSN
- 1474-9718 (ISSN-L)
- 1474-9726
- OpenAlex
- W1521953979
- Cited by
- 44
- References
- 19
- FWCI
- 2.70
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Accelerated hematopoietic stem cell aging in a mouse model of dyskeratosis congenita responds to antioxidant treatment. https://app.cochat.ai/papers/10.1111/j.1474-9726.2011.00674.x
- The paper
- Gu, B., Fan, J., Bessler, M., & Mason, P. J. (2011). Accelerated hematopoietic stem cell aging in a mouse model of dyskeratosis congenita responds to antioxidant treatment. Aging Cell. https://doi.org/10.1111/j.1474-9726.2011.00674.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.